{"title":"RNA Mis-Splicing Effects of Noncanonical Splicing Variants in Limb-Girdle Muscular Dystrophy Type R1/2A.","authors":"Guangyu Wang, Haoyang Liu, Guiguan Yang, Shen Gu, Chuanzhu Yan, Pengfei Lin","doi":"10.1212/NXG.0000000000200259","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Biallelic pathogenic variants in the <i>CAPN3</i> gene cause limb-girdle muscular dystrophy type R1/2A (LGMDR1/2A). Our study investigated RNA mis-splicing effects of 5 noncanonical intronic variants in patients with LGMDR1/2A.</p><p><strong>Methods: </strong>Total RNA was obtained from the skeletal muscle samples of patients with LGMDR1/2A. Reverse-transcription PCR, DNA electrophoresis, agarose gel extraction, pMD18-T vector cloning, and sequencing were conducted.</p><p><strong>Results: </strong>Transcriptional analysis revealed that three of these 5 variants (c.1193 + 30G > A, c.1194-9A > G, and c.1354 + 5G > A) induced CAPN3 pre-mRNA mis-splicing through recognition of cryptic donor or acceptor splice sites. In addition, the c.2185-14T > G variant in the polypyrimidine tract of intron 20 caused the pseudoexonization of the entire intron 20 while the c.946-29T > C variant in the branch point sequence (BPS) of intron 6 led to the retention of the last 390 bp of intron 6 through disruption of original BPS and recognition of cryptic BPS and acceptor splice site. All of these noncanonical splicing variants triggering pre-mRNA mis-splicing were predicted to introduce premature termination codons. Western blotting showed deficiency of full-length (94-kDa) and 60-kDa autolytic fragments of the calpain 3 protein in skeletal muscle samples from 4 probands.</p><p><strong>Discussion: </strong>Our study broadens the spectrum of aberrant mRNA splicing caused by intronic variants in calpainopathy.</p>","PeriodicalId":48613,"journal":{"name":"Neurology-Genetics","volume":"11 3","pages":"e200259"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11969717/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology-Genetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXG.0000000000200259","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Biallelic pathogenic variants in the CAPN3 gene cause limb-girdle muscular dystrophy type R1/2A (LGMDR1/2A). Our study investigated RNA mis-splicing effects of 5 noncanonical intronic variants in patients with LGMDR1/2A.
Methods: Total RNA was obtained from the skeletal muscle samples of patients with LGMDR1/2A. Reverse-transcription PCR, DNA electrophoresis, agarose gel extraction, pMD18-T vector cloning, and sequencing were conducted.
Results: Transcriptional analysis revealed that three of these 5 variants (c.1193 + 30G > A, c.1194-9A > G, and c.1354 + 5G > A) induced CAPN3 pre-mRNA mis-splicing through recognition of cryptic donor or acceptor splice sites. In addition, the c.2185-14T > G variant in the polypyrimidine tract of intron 20 caused the pseudoexonization of the entire intron 20 while the c.946-29T > C variant in the branch point sequence (BPS) of intron 6 led to the retention of the last 390 bp of intron 6 through disruption of original BPS and recognition of cryptic BPS and acceptor splice site. All of these noncanonical splicing variants triggering pre-mRNA mis-splicing were predicted to introduce premature termination codons. Western blotting showed deficiency of full-length (94-kDa) and 60-kDa autolytic fragments of the calpain 3 protein in skeletal muscle samples from 4 probands.
Discussion: Our study broadens the spectrum of aberrant mRNA splicing caused by intronic variants in calpainopathy.
期刊介绍:
Neurology: Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. Original articles in all areas of neurogenetics will be published including rare and common genetic variation, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease-genes, and genetic variations with a putative link to diseases. This will include studies reporting on genetic disease risk and pharmacogenomics. In addition, Neurology: Genetics will publish results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology: Genetics, but studies using model systems for treatment trials are welcome, including well-powered studies reporting negative results.